The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer
Open accessAbstract
Background: The primary goal of human papillomavirus (HPV) vaccination is to reduce morbidity and mortality from HPV-associated disease, especially cervical cancer. We determined the real-world effectiveness of HPV vaccination against cervical cancer. Methods: The study included women aged 17-30 years living in Denmark October 2006-December 2019. From nationwide registries, information on HPV vaccination and cervical cancer diagnoses were retrieved. Incidence rate ratios (IRRs) with 95% confidence intervals (CIs) for cervical cancer according to vaccination status were estimated using Poisson regression with HPV vaccination treated as a time-varying variable and stratified by age at vaccination. We adjusted for attained age, education, and ethnicity. To address the effect of prevalent disease, different buffer periods were used, with 1-year buffer period as primary analysis. Results: The cohort comprised 867 689 women. At baseline, 36.3% were vaccinated at age 16 years and younger, and during follow-up, 19.3% and 2.3% were vaccinated at ages 17-19 years and 20-30 years, respectively. For women vaccinated at ages 16 years and younger or 17-19 years, the IRRs of cervical cancer were 0.14 (95% CI = 0.04 to 0.53) and 0.32 (95% CI = 0.08 to 1.28), respectively, compared with unvaccinated women. In women aged 20-30 years at vaccination, the incidence rate was higher than among unvaccinated women (IRR = 1.19, 95% CI = 0.80 to 1.79) but slightly decreased with increasing buffer period (IRR = 0.85, 95% CI = 0.55 to 1.32, with 4-year buffer period). Conclusion: HPV vaccine effectiveness against cervical cancer at the population level is high among girls vaccinated younger than age 20 years. The lack of immediate effect in women vaccinated at age 20-30 years points to the importance of early age at vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
The Danish Civil Registration System as a tool in epidemiology
Schmidt, M., Pedersen, L., & Sørensen, H. T. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9930-3 · Cited by 3,441
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
The Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
Worldwide burden of cancer attributable to HPV by site, country and HPV type
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30716 · Cited by 2,322
HPV Vaccination and the Risk of Invasive Cervical Cancer
Lei, J., Ploner, A., Elfström, K. M., Wang, J., Roth, A., Fang, F., Sundström, K., Dillner, J., & Sparén, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917338 · Cited by 1,487
Jensen, V. M., & Rasmussen, A. W. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394715 · Cited by 1,471
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M.-C., Baldo, V., Brassard, P., Brotherton, J. M. L., Callander, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30298-3 · Cited by 1,384
Self-citationThe Danish National Health Service Register
Sahl Andersen, J., De Fine Olivarius, N., & Krasnik, A. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394718 · Cited by 890
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Self-citationBjerregaard, B., & Larsen, O. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810393563 · Cited by 404
Serrano, B., de Sanjosé, S., Tous, S., Quiros, B., Muñoz, N., Bosch, X., & Alemany, L. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.001 · Cited by 231
Tjalma, W. A., Fiander, A., Reich, O., Powell, N., Nowakowski, A. M., Kirschner, B., Koiss, R., O'Leary, J., Joura, E. A., Rosenlund, M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27713 · Cited by 218
Baldur-Felskov, B., Dehlendorff, C., Munk, C., & Kjaer, S. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt460 · Cited by 186
Self-citationSafety of Human Papillomavirus Vaccines: An Updated Review
Phillips, A., Patel, C., Pillsbury, A., Brotherton, J. M. L., & Macartney, K. K. (2017) · Drug Safety · doi:10.1007/s40264-017-0625-z · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Hildesheim, A., Wacholder, S., Catteau, G., Struyf, F., Dubin, G. O., & Herrero, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.038 · Cited by 131
Resilience of HPV vaccine uptake in Denmark: Decline and recovery
Hansen, P. R., Schmidtblaicher, M., & Brewer, N. T. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.12.019 · Cited by 114
Schreiber, S. M. S., Juul, K. E., Dehlendorff, C., & Kjær, S. K. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.12.008 · Cited by 98
Self-citationAn overview of cervical cancer epidemiology and prevention in Scandinavia
Pedersen, K., Fogelberg, S., Thamsborg, L. H., Clements, M., Nygård, M., Kristiansen, I. S., Lynge, E., Sparén, P., Kim, J. J., & Burger, E. A. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13313 · Cited by 91
Jensen, K. E., Hannibal, C. G., Nielsen, A., Jensen, A., Nøhr, B., Munk, C., & Kjær, S. K. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.014 · Cited by 83
Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997–2012
Baldur-Felskov, B., Munk, C., Nielsen, T. S. S., Dehlendorff, C., Kirschner, B., Junge, J., & Kjaer, S. K. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0603-7 · Cited by 76
Self-citationVerdoodt, F., Dehlendorff, C., & Kjær, S. K. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz239 · Cited by 63
Self-citationLoop electrosurgical excision of the cervix and the subsequent risk of preterm delivery
Nøhr, B., Tabor, A., Frederiksen, K., & Kjær, S. K. (2007) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340701279145 · Cited by 61
Jensen, K. E., Schmiedel, S., Frederiksen, K., Norrild, B., Iftner, T., & Kjær, S. K. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0663 · Cited by 48
Mølbak, K., Hansen, N. D., & Valentiner‐Branth, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162520 · Cited by 44
Dehlendorff, C., Sparén, P., Baldur‐Felskov, B., Herweijer, E., Arnheim‐Dahlström, L., Ploner, A., Uhnoo, I., & Kjær, S. K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.09.011 · Cited by 43
Self-citationde la Cour, C. D., Guleria, S., Nygård, M., Tryggvadóttír, L., Sigurðsson, K., Liaw, K., Hortlund, M., Lagheden, C., Hansen, B. T., Munk, C., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.1961 · Cited by 38
Cervical cancer incidence in Denmark over six decades (1943–2002)
Kyndi, M., Frederiksen, K., & Kjær, S. K. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340500324423 · Cited by 35
Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy
Faber, M. T., Duun‐Henriksen, A. K., Dehlendorff, C., Tatla, M. K., Munk, C., & Kjær, S. K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.030 · Cited by 25
Self-citationBaandrup, L., Dehlendorff, C., & Kjær, S. K. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1067 · Cited by 22
Self-citationHigh‐grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study
Thamsborg, L., Napolitano, G., Larsen, L. G., & Lynge, E. (2020) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13935 · Cited by 16
Cited by
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Kamolratanakul, S., & Pitisuttithum, P. (2021) · Vaccines · doi:10.3390/vaccines9121413 · Cited by 263
Cancer of the cervix uteri: 2025 update
Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70277 · Cited by 58
Metadata
- Authors
- Kjaer, S. K., Dehlendorff, C., Belmonte, F., & Baandrup, L.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-20
- Volume
- 113
- Issue
- 10
- Pages
- 1329-1335
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W3155806990
- Cited by
- 304
- References
- 33
- FWCI
- 27.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.